Sign in

CIK 0001703647

  • Non-accelerated filer
  • Smaller reporting company

Korro Bio, Inc.

Sign in to watch
Ticker
KRRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472324450
Phone
+1 617-468-1999
Business address
60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
Former names
Frequency Therapeutics, Inc.
Open-market buys, last 90 days
$884,752
in 1 filing
Open-market sales, last 90 days
$1,763,410
in 5 filings, $1.8M under 10b5-1 plans

Net −$878,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 5 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-12-17 Lucchino David L. President and CEO Exercise or conversion · Stock Option −1,120 288,910
2020-12-17 Loose Christopher R. Chief Scientific Officer Sale −6,000 $40.00 $240K 41,782
2020-12-17 Loose Christopher R. Chief Scientific Officer Sale −2,000 $42.50 $85K 39,782
2020-12-16 Lucchino David L. President and CEO Exercise or conversion +13,514 $0.61 $8K 337,314
2020-12-16 Lucchino David L. President and CEO Sale −13,514 $40.00 $541K 323,800
2020-12-16 Lucchino David L. President and CEO Exercise or conversion · Stock Option −13,514 290,030
2020-12-16 Loose Christopher R. Chief Scientific Officer Sale −4,000 $37.87 $151K 51,782
2020-12-16 Loose Christopher R. Chief Scientific Officer Sale −4,000 $40.00 $160K 47,782
2020-12-15 Lucchino David L. President and CEO Exercise or conversion +6,411 $0.61 $4K 330,211
2020-12-15 Lucchino David L. President and CEO Exercise or conversion +7,103 $0.61 $4K 337,314
2020-12-15 Lucchino David L. President and CEO Sale −9,014 $38.18 $344K 328,300
2020-12-15 Lucchino David L. President and CEO Sale −4,500 $38.83 $175K 323,800
2020-12-15 Lucchino David L. President and CEO Exercise or conversion · Stock Option −6,411 3,913
2020-12-15 Lucchino David L. President and CEO Exercise or conversion · Stock Option −7,103 303,544
2020-12-15 Loose Christopher R. Chief Scientific Officer Sale −8,000 $37.28 $298K 55,782
2020-12-14 Lucchino David L. President and CEO Exercise or conversion +13,514 $0.61 $8K 337,314
2020-12-14 Lucchino David L. President and CEO Sale −13,514 $35.12 $475K 323,800
2020-12-14 Lucchino David L. President and CEO Exercise or conversion · Stock Option −13,514 10,324
2020-12-14 Loose Christopher R. Chief Scientific Officer Sale −8,000 $35.00 $280K 63,782
2020-12-09 Lucchino David L. President and CEO Exercise or conversion +13,514 $0.61 $8K 337,314

Page 27 of 34 · 670 trades